Silo Pharma Inc (SILO)

$0.36 +0.01 (2.95%)
Market Cap 4.90M
Revenue (ttm) 70,000.00
Net Income (ttm) -4.23M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -6,042.86%
Debt to Equity Ratio 0.00
Volume 16,458,801
Avg Vol 1,498,718
Day's Range N/A - N/A
Shares Out 14.17M
Stochastic %K 34%
Beta 0.35
Analysts Strong Sell
Price Target $10.00

Company Profile

Silo Pharma Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including post-traumatic stress disorder (PTSD), stress-induced anxiety disorders, fibromyalgia, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders....

Industry: Biotechnology
Sector: Healthcare
Phone: 718 400 9031
Address:
677 North Washington Boulevard, Sarasota, United States
giancachimi
giancachimi Apr. 7 at 5:59 AM
$CUPR $SILO $MIGI $AIXI $MLEC
0 · Reply
PaulLaurent
PaulLaurent Apr. 7 at 5:29 AM
🌅 4:00am EST Watchlist — April 7, 2026 $CUPR – No confirmed same-night headline, so this looks more like a thin-float momentum setup. The latest backdrop is its Saudi MEDIFLY regulatory milestone, but cash and runway concerns keep financing risk in focus. ⚠️ $SILO – Silo had a real catalyst after the EPO signaled intent to grant a patent tied to prophylactic use of 5-HT4 receptor agonists. Traders will be watching whether the biotech IP headline can keep momentum alive. 🧬 $MIGI – Mawson announced a board reset through a cooperation deal with Endeavor, adding new directors while others resigned. The governance shake-up adds fresh attention alongside its broader AI and high-performance computing pivot. 🚀 Potential multi-day runners: $AIXI ✅ $MLEC ✅
0 · Reply
PSM_EmpowerTrading
PSM_EmpowerTrading Apr. 7 at 2:58 AM
🌅 Watchlist part 2 ✅ $SILO .50 support, if above .60, have potential to .70/.75 ✅ $MIGI 3 support, if above 3.65, have potential to 3.80/4 ✅ $TBH .50 support, if above .65, have potential to .70/.80 🚨 The above tickers are not ideal for swing accumulation at current price 🚨 ✅ Ideal long entry near low current support 🎯 Ideal stop loss if below current support 🚨 Avoid chasing long into strength near resistance ⏳⏳ $MXCT $NNOX still in swing accumulation phase 🎯🎯 Goal is GREEN, not GREED
0 · Reply
AlertsAndNews
AlertsAndNews Apr. 7 at 2:57 AM
Updated gappers in after hours trading $CUPR $ADVB $HCAI $SILO $MIGI Cheers!
0 · Reply
SadyK189
SadyK189 Apr. 7 at 2:07 AM
Top Stocks to watch tomorrow 1 / 2: $AIXI $MLEC $SIDU $MIGI $SILO AIXI: Alerted at 0.1644 yesterday. Moved massively to 0.84 now. Key support at 0.63 - 0.6750. Next key level to test 1.07 - 1.15. MLEC: Good close of daily candle. Key support at 9.2 - 9.65. Next key level to test 12.30 - 12.70. Currently at 10.94 SIDU: Alerted at 3.04 yesterday. Currently at 3.66. Looking good on daily chart. Key support at 2.75 - 3. Next key level to test 4.15 - 4.40. MIGI: Looking good on 4hours chart. 2.2 - 2.45 is acting as key support zone. Next key level to test 3.8 - 4.1. Currently at 3.28 SILO: Good close of 4hours candle. Key support at 0.34 - 0.38. Next key level to test 0.66 - 0.7. Currenty at 0.52.
0 · Reply
Stock_Catcher
Stock_Catcher Apr. 7 at 1:51 AM
Treasure Tuesday Watchlist Pt. 1 $AIXI $HCAI $IOBT $MIGI $SILO I will look for another 515%+ Runner
0 · Reply
Johnnytwofour
Johnnytwofour Apr. 7 at 1:24 AM
$SILO News is weak but company is beaten to hell. Might make a run out of it. Holding up well so far in the overnight.
0 · Reply
SlamminSammmy
SlamminSammmy Apr. 7 at 12:42 AM
$SILO imagine getting ind approval this thing will go at least 1.5
0 · Reply
30PERCENT30
30PERCENT30 Apr. 6 at 11:57 PM
$SILO Nice 🤑🤑🤑🤑
0 · Reply
KevMomentum
KevMomentum Apr. 6 at 11:43 PM
$SILO - "Silo Pharma gets European Patent Office allowance for PTSD prevention therapy" After-hours gapper here on SILO, so will ultimately need to see how this opens up before considering any actual entries here... but for now, SUPER simple plan here. Simply looking for the S/D flip setup, but this is really high confluence... see details below 👇
0 · Reply
Latest News on SILO
Silo Pharma Receives European Patent Allowance for Licensed Novel PTSD Prevention Therapy

Apr 6, 2026, 4:15 PM EDT - 9 hours ago

Silo Pharma Receives European Patent Allowance for Licensed Novel PTSD Prevention Therapy

Silo Pharma Announces Share Buyback Program

Feb 23, 2026, 4:15 PM EST - 6 weeks ago

Silo Pharma Announces Share Buyback Program

Silo Pharma Receives Notice of Allowance in Japan for SPC-15, Expanding Global Intellectual Property Portfolio

Feb 18, 2026, 8:28 AM EST - 6 weeks ago

Silo Pharma Receives Notice of Allowance in Japan for SPC-15, Expanding Global Intellectual Property Portfolio

Silo Pharma Executes Letter of Intent with Allucent to Support Phase 1 Clinical Development of SPC-15

Dec 30, 2025, 8:05 AM EST - 3 months ago

Silo Pharma Executes Letter of Intent with Allucent to Support Phase 1 Clinical Development of SPC-15

Silo Pharma Partners with Allucent to Support Planned FDA Investigational New Drug Application for SPC-15 as a Therapeutic for PTSD

Nov 17, 2025, 8:05 AM EST - 5 months ago

Silo Pharma Partners with Allucent to Support Planned FDA Investigational New Drug Application for SPC-15 as a Therapeutic for PTSD

Silo Pharma Selects Alphaledger's T12 Fund for Tokenized Real-World Asset Investments on Solana Blockchain

Oct 29, 2025, 8:25 AM EDT - 5 months ago

Silo Pharma Selects Alphaledger's T12 Fund for Tokenized Real-World Asset Investments on Solana Blockchain

Silo Pharma Issues Update on Milestone Achievements in PTSD Drug Development and New Digital Assets Treasury Program

Oct 23, 2025, 8:45 AM EDT - 5 months ago

Silo Pharma Issues Update on Milestone Achievements in PTSD Drug Development and New Digital Assets Treasury Program

Silo Pharma Expands Crypto Treasury with First Strategic Bitcoin Purchase Reinforcing Company's Commitment to Multi-Chain Growth

Oct 8, 2025, 8:45 AM EDT - 6 months ago

Silo Pharma Expands Crypto Treasury with First Strategic Bitcoin Purchase Reinforcing Company's Commitment to Multi-Chain Growth

Silo Pharma Acquires ResearchCoin (RSC) Crypto Tokens in Support of Decentralized Science (DeSci)

Oct 6, 2025, 8:10 AM EDT - 6 months ago

Silo Pharma Acquires ResearchCoin (RSC) Crypto Tokens in Support of Decentralized Science (DeSci)

Silo Pharma Announces Closing of $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Oct 1, 2025, 4:20 PM EDT - 6 months ago

Silo Pharma Announces Closing of $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Silo Pharma Announces $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Sep 30, 2025, 8:02 AM EDT - 6 months ago

Silo Pharma Announces $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Silo Pharma Announces Initial Investment in Ethereum and Solana under Cryptocurrency Treasury Strategy

Sep 16, 2025, 8:11 AM EDT - 7 months ago

Silo Pharma Announces Initial Investment in Ethereum and Solana under Cryptocurrency Treasury Strategy

Silo Pharma Adds Japanese Patent to Expanding Global IP Portfolio for Licensed PTSD Drug

Sep 9, 2025, 9:10 AM EDT - 7 months ago

Silo Pharma Adds Japanese Patent to Expanding Global IP Portfolio for Licensed PTSD Drug

Silo Pharma Secures Australian Patent Covering Licensed PTSD Drug Candidate Expanding Global IP Portfolio

Sep 3, 2025, 8:25 AM EDT - 7 months ago

Silo Pharma Secures Australian Patent Covering Licensed PTSD Drug Candidate Expanding Global IP Portfolio

Silo Pharma's Alzheimer's Candidate SPC-14 Featured in Leading Scientific Peer-reviewed Journal

Aug 21, 2025, 2:00 PM EDT - 8 months ago

Silo Pharma's Alzheimer's Candidate SPC-14 Featured in Leading Scientific Peer-reviewed Journal

Silo Pharma's PTSD Candidate SPC-15 Achieves Positive Safety Milestone, Paving Way for Accelerated Clinical Trials Under 505(b)(2) Pathway

Aug 19, 2025, 8:05 AM EDT - 8 months ago

Silo Pharma's PTSD Candidate SPC-15 Achieves Positive Safety Milestone, Paving Way for Accelerated Clinical Trials Under 505(b)(2) Pathway

Silo Pharma Appoints Crypto Infrastructure Pioneer Corwin Yu to Launch Institutional Bitcoin, Ethereum and Solana Treasury Platform

Aug 5, 2025, 8:32 AM EDT - 8 months ago

Silo Pharma Appoints Crypto Infrastructure Pioneer Corwin Yu to Launch Institutional Bitcoin, Ethereum and Solana Treasury Platform

Silo Pharma Announces Completion of Dosing in Safety Study of PTSD Drug SPC-15

Jul 16, 2025, 8:45 AM EDT - 9 months ago

Silo Pharma Announces Completion of Dosing in Safety Study of PTSD Drug SPC-15

Silo Pharma Advances PTSD Drug SPC-15 Toward Planned 2025 IND Submission with Pre-Clinical Study Data Expected in Q3 2025

Jul 7, 2025, 8:15 AM EDT - 9 months ago

Silo Pharma Advances PTSD Drug SPC-15 Toward Planned 2025 IND Submission with Pre-Clinical Study Data Expected in Q3 2025

Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market

Jun 25, 2025, 8:38 AM EDT - 10 months ago

Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market

Hoth Therapeutics (HOTH) and Silo Pharma (NASDAQ: SILO) today announced the formation of a 50/50 joint venture to develop a first-in-class GDNF-based therapy licensed from the U.S. Department of Veterans Affairs. The therapy targets obesity and fatty liver disease.

Jun 25, 2025, 8:27 AM EDT - 10 months ago

Hoth Therapeutics (HOTH) and Silo Pharma (NASDAQ: SILO) today announced the formation of a 50/50 joint venture to develop a first-in-class GDNF-based therapy licensed from the U.S. Department of Veterans Affairs. The therapy targets obesity and fatty liver disease.

HOTH

Silo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial Nears

Jun 11, 2025, 9:00 AM EDT - 10 months ago

Silo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial Nears

Silo Pharma Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset

Jun 5, 2025, 9:15 AM EDT - 10 months ago

Silo Pharma Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset

Silo Pharma Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15

May 21, 2025, 8:55 AM EDT - 11 months ago

Silo Pharma Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15

Silo Pharma Announces Closing of $2 Million Public Offering

May 16, 2025, 4:15 PM EDT - 11 months ago

Silo Pharma Announces Closing of $2 Million Public Offering

Silo Pharma Announces Pricing of $2 Million Public Offering

May 15, 2025, 9:15 AM EDT - 11 months ago

Silo Pharma Announces Pricing of $2 Million Public Offering

Silo Pharma Selects Veloxity Labs for Bioanalytical IND-Enabling Study for our Novel Intranasal PTSD Therapy, SPC-15

May 14, 2025, 4:07 PM EDT - 11 months ago

Silo Pharma Selects Veloxity Labs for Bioanalytical IND-Enabling Study for our Novel Intranasal PTSD Therapy, SPC-15

Silo Pharma Advances PTSD Drug SPC-15 Toward First-in-Human Trial with Key Safety Study Initiated at Frontage Laboratories

May 14, 2025, 8:40 AM EDT - 11 months ago

Silo Pharma Advances PTSD Drug SPC-15 Toward First-in-Human Trial with Key Safety Study Initiated at Frontage Laboratories

Silo Pharma's SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia Study

Apr 30, 2025, 8:11 AM EDT - 1 year ago

Silo Pharma's SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia Study

Silo Pharma Expands Intellectual Property Portfolio with Patent Application for Exclusively Licensed Alzheimer's Drug

Apr 28, 2025, 7:50 AM EDT - 1 year ago

Silo Pharma Expands Intellectual Property Portfolio with Patent Application for Exclusively Licensed Alzheimer's Drug

Silo Pharma Achieves Key Milestone with First Dosing in IND-Enabling GLP Study for SPC-15 as a Groundbreaking PTSD Treatment

Mar 26, 2025, 8:40 AM EDT - 1 year ago

Silo Pharma Achieves Key Milestone with First Dosing in IND-Enabling GLP Study for SPC-15 as a Groundbreaking PTSD Treatment

Silo Pharma Granted U.S. Patent for Novel Intranasal Post-Traumatic Stress Disorder Treatment

Feb 26, 2025, 1:30 PM EST - 1 year ago

Silo Pharma Granted U.S. Patent for Novel Intranasal Post-Traumatic Stress Disorder Treatment

Silo Pharma Expands Intellectual Property Portfolio with Provisional Patent Filing for Innovative SPC-15 Combination Treatment

Feb 18, 2025, 8:50 AM EST - 1 year ago

Silo Pharma Expands Intellectual Property Portfolio with Provisional Patent Filing for Innovative SPC-15 Combination Treatment

Silo Pharma Announces Positive Initial Pharmacokinetic, Safety, and Tolerability Study of SP-26 for Chronic Pain and Fibromyalgia

Feb 11, 2025, 7:45 AM EST - 1 year ago

Silo Pharma Announces Positive Initial Pharmacokinetic, Safety, and Tolerability Study of SP-26 for Chronic Pain and Fibromyalgia

Silo Pharma Advances Intellectual Property Portfolio with Provisional Patent Filing for PTSD Treatment

Jan 22, 2025, 8:29 AM EST - 1 year ago

Silo Pharma Advances Intellectual Property Portfolio with Provisional Patent Filing for PTSD Treatment

Silo Pharma Issues Letter to Shareholders Detailing Development Progress and Potential for Lead Assets Targeting PTSD and Chronic Pain

Jan 2, 2025, 8:45 AM EST - 1 year ago

Silo Pharma Issues Letter to Shareholders Detailing Development Progress and Potential for Lead Assets Targeting PTSD and Chronic Pain

Silo Pharma Initiates Pharmacokinetic and Tolerability Study for SP-26 Targeting Chronic Pain and Fibromyalgia

Dec 18, 2024, 7:35 AM EST - 1 year ago

Silo Pharma Initiates Pharmacokinetic and Tolerability Study for SP-26 Targeting Chronic Pain and Fibromyalgia

Silo Pharma Enters Joint Development Agreement for SP-26 Ketamine Implant Device Targeting Pain Management

Nov 29, 2024, 8:05 AM EST - 1 year ago

Silo Pharma Enters Joint Development Agreement for SP-26 Ketamine Implant Device Targeting Pain Management

Silo Pharma Announces Positive Results for Novel SPC-15 Treatment Targeting Stress-Related Disorders

Nov 18, 2024, 8:40 AM EST - 1 year ago

Silo Pharma Announces Positive Results for Novel SPC-15 Treatment Targeting Stress-Related Disorders

Silo Pharma Reports Positive Results in Sterilization and Dissolution Testing of SP-26 Ketamine Implant

Oct 31, 2024, 8:35 AM EDT - 1 year ago

Silo Pharma Reports Positive Results in Sterilization and Dissolution Testing of SP-26 Ketamine Implant

Silo Pharma Announces Completion of FDA Pre-IND Meeting to Advance Development of SPC-15 for Treatment of PTSD

Sep 10, 2024, 6:35 AM EDT - 1 year ago

Silo Pharma Announces Completion of FDA Pre-IND Meeting to Advance Development of SPC-15 for Treatment of PTSD

Silo Pharma Expands Development Agreement with Sever Pharma for Novel Ketamine Implant Therapeutic

Aug 14, 2024, 2:30 PM EDT - 1 year ago

Silo Pharma Expands Development Agreement with Sever Pharma for Novel Ketamine Implant Therapeutic

Silo Pharma Announces Partnership with Global CRO for Central Nervous System Homing Peptide

Aug 7, 2024, 8:13 AM EDT - 1 year ago

Silo Pharma Announces Partnership with Global CRO for Central Nervous System Homing Peptide

Silo Pharma to Present at H.C. Wainwright Annual Global Investment Conference

Jul 26, 2024, 8:20 AM EDT - 1 year ago

Silo Pharma to Present at H.C. Wainwright Annual Global Investment Conference

Silo Pharma Announces Closing of $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Jul 22, 2024, 4:45 PM EDT - 1 year ago

Silo Pharma Announces Closing of $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Silo Pharma Announces $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Jul 19, 2024, 8:01 AM EDT - 1 year ago

Silo Pharma Announces $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Silo Pharma Finds Partner For Device Development for Intranasal PTSD Drug

Jul 18, 2024, 12:44 PM EDT - 1 year ago

Silo Pharma Finds Partner For Device Development for Intranasal PTSD Drug

Silo Pharma and Resyca BV Partner on Device and CMC Development for Intranasal PTSD Drug SPC-15

Jul 18, 2024, 8:25 AM EDT - 1 year ago

Silo Pharma and Resyca BV Partner on Device and CMC Development for Intranasal PTSD Drug SPC-15

Why Is Nano-Cap Silo Pharma Stock Skyrocketing On Tuesday?

Jul 16, 2024, 10:50 AM EDT - 1 year ago

Why Is Nano-Cap Silo Pharma Stock Skyrocketing On Tuesday?

Silo Pharma Secures Exclusive Global License for Alzheimer's Therapeutic

Jul 16, 2024, 6:30 AM EDT - 1 year ago

Silo Pharma Secures Exclusive Global License for Alzheimer's Therapeutic

giancachimi
giancachimi Apr. 7 at 5:59 AM
$CUPR $SILO $MIGI $AIXI $MLEC
0 · Reply
PaulLaurent
PaulLaurent Apr. 7 at 5:29 AM
🌅 4:00am EST Watchlist — April 7, 2026 $CUPR – No confirmed same-night headline, so this looks more like a thin-float momentum setup. The latest backdrop is its Saudi MEDIFLY regulatory milestone, but cash and runway concerns keep financing risk in focus. ⚠️ $SILO – Silo had a real catalyst after the EPO signaled intent to grant a patent tied to prophylactic use of 5-HT4 receptor agonists. Traders will be watching whether the biotech IP headline can keep momentum alive. 🧬 $MIGI – Mawson announced a board reset through a cooperation deal with Endeavor, adding new directors while others resigned. The governance shake-up adds fresh attention alongside its broader AI and high-performance computing pivot. 🚀 Potential multi-day runners: $AIXI ✅ $MLEC ✅
0 · Reply
PSM_EmpowerTrading
PSM_EmpowerTrading Apr. 7 at 2:58 AM
🌅 Watchlist part 2 ✅ $SILO .50 support, if above .60, have potential to .70/.75 ✅ $MIGI 3 support, if above 3.65, have potential to 3.80/4 ✅ $TBH .50 support, if above .65, have potential to .70/.80 🚨 The above tickers are not ideal for swing accumulation at current price 🚨 ✅ Ideal long entry near low current support 🎯 Ideal stop loss if below current support 🚨 Avoid chasing long into strength near resistance ⏳⏳ $MXCT $NNOX still in swing accumulation phase 🎯🎯 Goal is GREEN, not GREED
0 · Reply
AlertsAndNews
AlertsAndNews Apr. 7 at 2:57 AM
Updated gappers in after hours trading $CUPR $ADVB $HCAI $SILO $MIGI Cheers!
0 · Reply
SadyK189
SadyK189 Apr. 7 at 2:07 AM
Top Stocks to watch tomorrow 1 / 2: $AIXI $MLEC $SIDU $MIGI $SILO AIXI: Alerted at 0.1644 yesterday. Moved massively to 0.84 now. Key support at 0.63 - 0.6750. Next key level to test 1.07 - 1.15. MLEC: Good close of daily candle. Key support at 9.2 - 9.65. Next key level to test 12.30 - 12.70. Currently at 10.94 SIDU: Alerted at 3.04 yesterday. Currently at 3.66. Looking good on daily chart. Key support at 2.75 - 3. Next key level to test 4.15 - 4.40. MIGI: Looking good on 4hours chart. 2.2 - 2.45 is acting as key support zone. Next key level to test 3.8 - 4.1. Currently at 3.28 SILO: Good close of 4hours candle. Key support at 0.34 - 0.38. Next key level to test 0.66 - 0.7. Currenty at 0.52.
0 · Reply
Stock_Catcher
Stock_Catcher Apr. 7 at 1:51 AM
Treasure Tuesday Watchlist Pt. 1 $AIXI $HCAI $IOBT $MIGI $SILO I will look for another 515%+ Runner
0 · Reply
Johnnytwofour
Johnnytwofour Apr. 7 at 1:24 AM
$SILO News is weak but company is beaten to hell. Might make a run out of it. Holding up well so far in the overnight.
0 · Reply
SlamminSammmy
SlamminSammmy Apr. 7 at 12:42 AM
$SILO imagine getting ind approval this thing will go at least 1.5
0 · Reply
30PERCENT30
30PERCENT30 Apr. 6 at 11:57 PM
$SILO Nice 🤑🤑🤑🤑
0 · Reply
KevMomentum
KevMomentum Apr. 6 at 11:43 PM
$SILO - "Silo Pharma gets European Patent Office allowance for PTSD prevention therapy" After-hours gapper here on SILO, so will ultimately need to see how this opens up before considering any actual entries here... but for now, SUPER simple plan here. Simply looking for the S/D flip setup, but this is really high confluence... see details below 👇
0 · Reply
Freshyone
Freshyone Apr. 6 at 11:37 PM
$SILO ~ grab it before premarket run
0 · Reply
Freshyone
Freshyone Apr. 6 at 10:23 PM
$SILO ~ am Gappa..
0 · Reply
dogood
dogood Apr. 6 at 9:56 PM
$IOBT come to $SILO
0 · Reply
El_Grande_Sniper
El_Grande_Sniper Apr. 6 at 9:47 PM
$SILO 3 lower highs and 3 lower lows so far, distribution...
0 · Reply
bullbear1234
bullbear1234 Apr. 6 at 9:44 PM
$SILO Up 38% on a European patent? meh
0 · Reply
dogood
dogood Apr. 6 at 9:43 PM
$SILO break .60
0 · Reply
walfofwallstreet
walfofwallstreet Apr. 6 at 9:39 PM
After hours top🔝 list 👀👀👀🐺 $IOBT $CUPR $SILO $RDGT Stay tuned everyone 👀🐺🐺🐺
1 · Reply
Johnnytwofour2
Johnnytwofour2 Apr. 6 at 9:30 PM
$SILO Oh no! topstockalerts just posted, that means this is about to take a big dump.
0 · Reply
topstockalerts
topstockalerts Apr. 6 at 9:29 PM
$SILO too strong to ignore!!
0 · Reply
flashdash
flashdash Apr. 6 at 9:14 PM
$SILO has a TINY MARKET CAP, but is targeting large markets. RFK Jr. and the FDA now seem to be supportive to companies like $SILO. The $SILO patent mentioned could become of interest down the road to VERY LARGE pharmaceutical companies.
0 · Reply
topstockalerts
topstockalerts Apr. 6 at 9:12 PM
After Hours Top Gainers $IOBT $CUPR $SILO $UNHG $HCAI
0 · Reply
Annet_why_net
Annet_why_net Apr. 6 at 9:11 PM
$SILO first pump...
0 · Reply